SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...
Persica Pharma announces positive phase 1b Modic trial of PP353, a novel, non-opioid intradiscal injection to treat chronic low back pain: London, UK Thursday, March 6, 2025, 18:0 ...
Evidence has shown that 25% of patients with chronic lower back pain could be suffering from an infection in the disc space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results